share_log

Piper Sandler Downgrades Mesoblast to Neutral, Lowers Price Target to $2

Benzinga ·  Aug 4, 2023 07:29

Piper Sandler analyst Edward Tenthoff downgrades Mesoblast (NASDAQ:MESO) from Overweight to Neutral and lowers the price target from $7 to $2.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment